About Kuros Biosciences
Kuros Biosciences develops MagnetOs bone graft granules and KUR-113 fibrin-PTH peptide hydrogel for spinal fusion and orthopedic bone regeneration applications.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Kuros Biosciences. Response typically within 48 hours.
Company Info
TypePublic
StockKURN (SIX)
Founded2001
Employees80
Revenue$14M
HQSchlieren, Switzerland
